Trial NCT04352608
Publication Pan H , medRxiv, 2021
Primary outcome on the report: Geometric mean titers (GMTs), seropositivity, and seroconversion rate of neutralizing antibodies to live SARS-CoV-2

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.